Compare · PLUS vs WGS
PLUS vs WGS
Side-by-side comparison of ePlus inc. (PLUS) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PLUS and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- WGS is the larger of the two at $3.02B, about 1.3x PLUS ($2.38B).
- Over the past year, PLUS is up 21.5% and WGS is down 22.3% - PLUS leads by 43.8 points.
- WGS has been more active in the news (9 items in the past 4 weeks vs 4 for PLUS).
- WGS has more recent analyst coverage (8 ratings vs 3 for PLUS).
- Company
- ePlus inc.
- GeneDx Holdings Corp.
- Price
- $91.03-1.10%
- $101.19-3.58%
- Market cap
- $2.38B
- $3.02B
- 1M return
- +5.38%
- +27.00%
- 1Y return
- +21.49%
- -22.32%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1996
- 2020
- News (4w)
- 4
- 9
- Recent ratings
- 3
- 8
ePlus inc.
ePlus inc., through its subsidiaries, provides information technology solutions that enable organizations to optimize their information technology (IT) environment and supply chain processes in the United States. It operates in two segments, Technology and Financing. The Technology segment offers hardware, perpetual and subscription software, maintenance, software assurance, and internally-provided and outsourced services; and professional and managed services, including ePlus managed, professional, security, ePlus Cloud Consulting, staff augmentation, server and desktop support, and project management services. The Financing segment specializes in leasing and financing arrangements, such as sales-type and operating leases; loans and consumption-based financing arrangements; and underwriting and management of IT equipment and assets. Its financing operations comprise sales, pricing, credit, contracts, accounting, risk management, and asset management. This segment primarily finances IT, communication-related, and medical equipment; and industrial machinery and equipment, office furniture and general office equipment, transportation equipment, and other general business equipment directly, as well as through vendors. ePlus inc. serves commercial entities, state and local governments, government contractors, and educational institutions. The company was formerly known as MLC Holdings, Inc. and changed its name to ePlus inc. in 1999. ePlus inc. was founded in 1990 and is headquartered in Herndon, Virginia.
Latest PLUS
- CHIEF OPERATING OFFICER Raiguel Darren S sold $12,979 worth of shares (139 units at $93.38) as part of a pre-agreed trading plan (SEC Form 4)
- CHIEF OPERATING OFFICER Raiguel Darren S sold $79,543 worth of shares (854 units at $93.14) as part of a pre-agreed trading plan (SEC Form 4)
- ePlus inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- ePlus Achieves Exclusive Ambassador Partner Status with Everpure
- ePlus Acquires Assets of Daymark Solutions
- Director Callies John E sold $44,043 worth of shares (500 units at $88.09), decreasing direct ownership by 2% to 20,648 units (SEC Form 4)
- CHIEF OPERATING OFFICER Raiguel Darren S sold $90,827 worth of shares (1,000 units at $90.83) as part of a pre-agreed trading plan (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by ePlus inc.
- CHIEF OPERATING OFFICER Raiguel Darren S sold $19,600 worth of shares (200 units at $98.00) as part of a pre-agreed trading plan (SEC Form 4)
- CHIEF FINANCIAL OFFICER Marion Elaine D sold $690,286 worth of shares (7,182 units at $96.11) as part of a pre-agreed trading plan (SEC Form 4)
Latest WGS
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $1,025,013 worth of shares (10,501 units at $97.61), increasing direct ownership by 8% to 115,476 units (SEC Form 4) (withholding obligation)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares and sold $363,892 worth of shares (3,728 units at $97.61), increasing direct ownership by 8% to 44,945 units (SEC Form 4) (tax withholding)
- Director Fuchs Thomas converted options into 1,146 shares (SEC Form 4)
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 6,547 shares and sold $310,932 worth of shares (3,692 units at $84.22), increasing direct ownership by 3% to 107,227 units (SEC Form 4) to cover taxes
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 2,462 shares and sold $108,220 worth of shares (1,285 units at $84.22), increasing direct ownership by 3% to 41,476 units (SEC Form 4) to satisfy tax liability
- GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $31,188 worth of shares (372 units at $83.84), increasing direct ownership by 0.86% to 40,299 units (SEC Form 4) to cover taxes
- SEC Form 144 filed by GeneDx Holdings Corp.
- GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree
- GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s